SELECT-2 Clinical Trial Assessing the Efficacy and Saftey of Controlled-Release Interferon Alpha-2B (CR2b)+Ribavirin (RBV) Versus Pegylated Interferon Alpha-2B (Peg2b)+RBV in Treatment-NaïVE Genotype-1 (G1) Hepatitis C
2011
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI